|
Spectrum of activity:
|
Gram-positive
&
Gram-negative
|
|
Details of activity:
|
Active against Salmonella enterica serovar Typhimurium, methicillin-resistant Staphylococcus aureus and colistin-resistant strains of Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii; disrupts integrity of cell membrane
|
|
Description:
|
Synthetic compound; repurposed nonsteroidal anti-inflammatory drug used to treat rheumatic conditions; sensitizer; no inhibitory activity on its own but shows synergistic effect with colistin
|
|
Institute where first reported:
|
Wenzhou Medical University, Wenzhou, Zhejiang Province, China
|
|
Year first mentioned:
|
2023
|
|
Development status:
|
Experimental
|